1637 Impact of Germline TP53 p.R72P Polymorphism on Response to Neoadjuvant Immune Checkpoint Inhibitor Therapy in NSCLC

View at publisher Summarise with VIRAT
Authors: Selin Kurt, Kritika Krishnamurthy
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Lung Cancer Treatments and Mutations Cancer-related Molecular Pathways

Publication details

Journal / source
Laboratory Investigation
Volume
106
Issue
3
Pages
105939–105939
Publication date
1 March 2026
Language
EN